Our CEO Liz Parrish spoke at Wired Health 2017 about why: Ageing is a disease. Gene therapy could be the 'cure'

"She (Liz Parrish) had spent more than two years studying literature, talking to experts, and had decided to undergo gene therapy – a treatment for genetic disorders that adds genes into cells to replace those that are faulty or absent."

“I was a person who quite honestly felt I had not really contributed that much to society and this was my opportunity to do so.”

“The company was built essentially to prove these therapies work or not,” Parrish says. “Remember BioViva is not a research organisation. We are taking things like gene therapies and using them like technology. We would like to create an open market where people have access to acquiring these technologies, much like you would acquire a cellphone or a computer.”

WIRED

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Liz Parrish - Gene Therapy to Treat the Diseases of Aging on NRK TV's Trygdekontoret

To go to Liz's section in this show click this link: https://youtu.be/E79mOjWDOIY?t=1444

Liz Parrish, CEO of BioViva, speaks about helping people live longer healthier lives by using gene and cell therapies. Liz was speaking at Norways NRK TV show Trygdekontoret.

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

WIRED Health 2017 London: Looking Into The Future of Healthcare

Last week WIRED Health gathered hundreds of leaders and influencers from across the globe in London to discuss the field of health innovation and technology. In addition to their long lists of honors and historic accolades, the unrivaled lineup of speakers brought an infectious enthusiasm for action in healthcare.

MedGadget

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

ABC Lateline: An Interview With Liz Parrish

Jeremy Fernandez speaks to Liz Parrish, the CEO of BioViva - an American biotech developing treatments to slow the ageing process in humans.

ABC Australia

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Adding ages: The fight to cheat death is hotting up

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Becoming the First Transhuman: A Call For The Right Stuff

Who will officially be the first transhuman? 

Transhumanity

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Can this woman cure ageing with gene therapy?

Elizabeth Parrish is CEO of BioViva, a Seattle-based biotech company working to develop treatments to slow the ageing process. In April, the company revealed that Parrish herself had undergone “the first gene therapy successful against human ageing”. The treatment, it claimed, had reversed the biological age of her immune cells by 20 years.

The Guardian 

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Did A Biotech CEO Reverse Her Own Aging Process?

According to BioViva and to interviews with its CEO, Elizabeth Parrish, Parrish received two therapies last year, one to protect against the loss of muscle mass, and one to lengthen her telomeres.

Forbes

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Gene doping in sport could make the Olympics fairer and safer

Elizabeth Parrish of the anti-ageing company BioViva claims to have given herself two kinds of experimental gene therapy, one of which blocks the breakdown of muscle tissue. In other words, your muscles stay strong even if you don’t exercise – and grow faster if you do.

New Scientist

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Biotech execs in search of human guinea pigs find eager subjects: themselves

Liz Parrish, CEO of the biotech BioViva USA Inc., was injected last September with two of the company’s experimental gene therapies. 

STAT News

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Liz Parrish Is Patient Zero in Her Own Anti-Aging Experiment

Elizabeth (Liz) Parrish is the CEO of BioViva, a biotechnology company that focuses on developing gene therapies, and other regenerative therapies, to intervene with human aging.Last September, Parrish added an interesting line to her job description: patient zero for two anti-aging therapies that the company is researching.

Discover Magazine

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

First Data from Anti-Aging Gene Therapy

A biotech company reports that an experimental treatment elongated its CEO’s telomeres. 

The Scientist

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Scientists Claim They've Completed the First Successful Gene Therapy Against Human Ageing

The CEO of Bioviva USA Inc, Elizabeth Parrish, claims to be the first human in world history to have successfully reversed the effects of natural ageing - thanks to experimental gene therapy provided by her company.

Science Alert

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Scientists Say They’ve Completed the First Ever Successful Gene Therapy to Combat Old Age

Elizabeth Parrish, the CEO of BioViva USA Inc, a biotechnology company that “aims to provide regenerative medicine to the masses through gene and cell therapies,” claims to be the first person in history to have successfully reversed one of the hallmark signs of aging with the company’s experimental gene therapy.

The Science Explorer

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Is Silicon Valley Birthing The Next Pro-Lifers?

Elizabeth Parrish is 44, the tough-gunning, sharp-talking CEO of a life-sciences startup, and seemingly full of life herself. But she says she suffers from a deadly disease. Hoping to stave off the sickness, Parrish recently journeyed to a clinic in Colombia, where she underwent a course of therapy that the FDA hasn’t touched with a 10-foot pole. One treatment would alter her telomeres — the stuff at the end of her DNA. The other would inhibit a protein that stops muscle growth.

OZY

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

A Tale of Do-It-Yourself Gene Therapy

Can aging be slowed by using gene therapy to make permanent changes to a person’s DNA?

MIT Technology Review

Comment

Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation (http://bit.ly/13WVyUW) and I have written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee

Anti-aging Gene Therapy: Has The Time Arrived For True Anti-aging Medicine?

Anti-aging Gene Therapy: Has The Time Arrived For True Anti-aging Medicine?

Now in 2016 it is becoming increasingly clear that therapies are emerging which could seriously impact aspects of the human aging process.

One of the most cutting-edge therapies that are now being tested is the use of viral vectors to lengthen telomeres, the DNA caps at the end of our chromosomes. Elizabeth Parrish, CEO of the company Bioviva USA inc, is the first person to treat human aging with this technology, using herself as a test subject.

Contrary to much buzz within the anti-aging field, this is certainly a valid treatment for a part of the aging problem in organisms, by preventing DNA from shortening. Back in 2012 this experiment was first set up in mice by Maria Blasco et al, using adeno viruses to lengthen telomeres in mice. The treated mice lived longer on average with no increased cancer rates, showing proof of principle.

Read More

First Gene Therapy Successful Against Human Aging

First Gene Therapy Successful Against Human Aging

In September 2015, then 44 year-old CEO of BioViva USA Inc. Elizabeth Parrish received two of her own company’s experimental gene therapies: one to protect against loss of muscle mass with age, another to battle stem cell depletion responsible for diverse age-related diseases and infirmities.

The treatment was originally intended to demonstrate the safety of the latest generation of the therapies. But if early data is accurate, it is already the world’s first successful example of telomere lengthening via gene therapy in a human individual. Gene therapy has been used to lengthen telomeres before in cultured cells and in mice, but never in a human patient.

Read More